CA2022146A1 - Anticorps monoclonaux immunosuppresseurs, hybridomes et methode de transplantation - Google Patents

Anticorps monoclonaux immunosuppresseurs, hybridomes et methode de transplantation

Info

Publication number
CA2022146A1
CA2022146A1 CA002022146A CA2022146A CA2022146A1 CA 2022146 A1 CA2022146 A1 CA 2022146A1 CA 002022146 A CA002022146 A CA 002022146A CA 2022146 A CA2022146 A CA 2022146A CA 2022146 A1 CA2022146 A1 CA 2022146A1
Authority
CA
Canada
Prior art keywords
hybridoma
reactive
antibody
monoclonal antibody
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002022146A
Other languages
English (en)
Inventor
John A. Hansen
Paul J. Martin
Claudio Anasetti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fred Hutchinson Cancer Center
Original Assignee
Fred Hutchinson Cancer Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fred Hutchinson Cancer Center filed Critical Fred Hutchinson Cancer Center
Publication of CA2022146A1 publication Critical patent/CA2022146A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2809—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against the T-cell receptor (TcR)-CD3 complex
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA002022146A 1989-07-27 1990-07-27 Anticorps monoclonaux immunosuppresseurs, hybridomes et methode de transplantation Abandoned CA2022146A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38690689A 1989-07-27 1989-07-27
US07/386,906 1989-07-27

Publications (1)

Publication Number Publication Date
CA2022146A1 true CA2022146A1 (fr) 1991-01-28

Family

ID=23527572

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002022146A Abandoned CA2022146A1 (fr) 1989-07-27 1990-07-27 Anticorps monoclonaux immunosuppresseurs, hybridomes et methode de transplantation

Country Status (2)

Country Link
CA (1) CA2022146A1 (fr)
WO (1) WO1991001752A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9206422D0 (en) * 1992-03-24 1992-05-06 Bolt Sarah L Antibody preparation
US5951983A (en) * 1993-03-05 1999-09-14 Universite Catholique De Louvain Methods of inhibiting T cell mediated immune responses with humanized LO-CD2A-specific antibodies
US5730979A (en) * 1993-03-05 1998-03-24 Universite Catholique Delouvain LO-CD2a antibody and uses thereof for inhibiting T cell activation and proliferation
US5817311A (en) * 1993-03-05 1998-10-06 Universite Catholique De Louvain Methods of inhibiting T-cell medicated immune responses with LO-CD2a-specific antibodies
US7592006B1 (en) 1993-03-05 2009-09-22 Université Catholique de Louvain Composition comprising the LO-CD2a antibody
US6849258B1 (en) 1997-07-18 2005-02-01 Universite Catholique De Louvain LO-CD2a antibody and uses thereof for inhibiting T cell activation and proliferation
US6541611B1 (en) 1999-06-18 2003-04-01 Universite Catholique De Louvain LO-CD2b antibody
CN105722859B (zh) 2013-07-25 2021-05-07 西托姆克斯治疗公司 多特异性抗体、多特异性可活化抗体及其使用方法
BR112016030740A2 (pt) 2014-07-01 2018-02-20 Pfizer Inc. diacorpos heterodiméricos biespecíficos e seus usos
JP7020909B2 (ja) 2014-07-25 2022-02-16 シトムクス セラピューティクス，インコーポレイティド 抗－ｃｄ３抗体、活性化可能抗－ｃｄ３抗体、多重特異的抗－ｃｄ３抗体、多重特異的活性化可能抗－ｃｄ３抗体、及びそれらの使用方法

Also Published As

Publication number Publication date
WO1991001752A1 (fr) 1991-02-21

Similar Documents

Publication Publication Date Title
JP2828340B2 (ja) ＩＬ―２レセプターのｐ５５ Ｔａｃタンパク質に特異的なキメラ免疫グロブリン
FI75183B (fi) Foerfarande foer framstaellning av en komplement-bindande monoklonal antikropp mot maenniskans t-celler genom anvaendning av en ny hybridcellinje.
JP2530316B2 (ja) 特異的抗原に対する免疫耐性賦与組成物
Hale et al. Remission induction in non-Hodgkin lymphoma with reshaped human monoclonal antibody CAMPATH-1H
EP0449769B1 (fr) Molécules liant à la CD25
US6210671B1 (en) Humanized antibodies reactive with L-selectin
US5091178A (en) Tumor therapy with biologically active anti-tumor antibodies
AU2005220211B2 (en) Immunotherapy of autoimmune disorders using antibodies which target B-cells
DE69032484T4 (de) Zusammensetzungen und deren verwendung zur förderung der immunopotentiation
US7247718B2 (en) Antibody recognizing a small subset of human hematopoietic cells
US20050037005A1 (en) 5c8 Antigen
US5635156A (en) Non-lethal methods for conditioning a recipient for bone marrow transplantation
CZ456090A3 (cs) Očkovací látka proti boreliose, způsob její výroby a monoklonální protilátky
US5011684A (en) Lysing or blocking unwanted cells with IL-2 receptor-specific binding substance
CA2055615C (fr) Anticorps monoclonaux pour induire la toterance
US5514364A (en) Non-lethal methods for conditioning a recipient for bone marrow transplantation
CA2022146A1 (fr) Anticorps monoclonaux immunosuppresseurs, hybridomes et methode de transplantation
US5084391A (en) Monoclonal antibody to the interleukin-2-receptor and its use
AU2002364398A1 (en) Therapeutic monoclonal anti-TIRC7 antibodies for use in immune related and other diseases
US5762933A (en) Method for preventing and treating graft failure in a human patient using a monoclonal antibody specific for leucocyte functional antigen LFA-1
Stockinger et al. T14, a non-modulating 150-kd T cell surface antigen
Waldmann et al. Monoclonal antibodies for immunosuppression
WO1986007382A1 (fr) Anticorps monoclonaux humains de protection contre l'exotoxine a produite par pseudomonas aeruginosa
Wooley et al. Immunotherapy of collagen-induced arthritis with anti-la and anti-IL-2R antibodies
Sy et al. T cell development in B cell-deficient mice. II. Serological characterization of suppressor T cell factors (TsF1) produced in normal mice and in mice treated chronically with rabbit anti-mouse IgM antibodies.

Legal Events

Date Code Title Description
FZDE Discontinued
FZDE Discontinued

Effective date: 19940127